Pfizer Covid-19 jab ‘100% effective’ in younger teenagers, research suggests

The Pfizer-BioNTech coronavirus vaccine has been trialled in children aged 12 to 15 (PA)

The Pfizer Covid-19 jab is “100% effective and well tolerated” among children aged 12 to 15, a new study suggests.

Pfizer said it now plans to seek approval for use of the vaccine in this age group from regulators around the world and hopes youngsters will start to receive the jab before the next school year.